Oncology Institute (TOI) Non-Current Deferred Tax Liability (2020 - 2025)

Oncology Institute (TOI) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $7.8 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 24171.88% year-over-year to $7.8 million; the trailing twelve-month figure through Dec 2025 stood at $7.8 million (up 24171.88% YoY), and the FY2025 full-year result was $7.8 million, up 24171.88% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2025 stood at $7.8 million, up from $32000.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $10.2 million in Q4 2023 and bottomed at $32000.0 in Q1 2024.
• The 5-year median for Non-Current Deferred Tax Liability is $158000.0 (2023), against an average of $1.9 million.
• The widest annual swing landed in 2024, when Non-Current Deferred Tax Liability slumped 99.69%; it then surged 24171.88% in 2025.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $371000.0 in 2021, then soared by 2244.47% to $8.7 million in 2022, then grew by 17.38% to $10.2 million in 2023, then plunged by 99.69% to $32000.0 in 2024, then soared by 24171.88% to $7.8 million in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $7.8 million (Q4 2025), $32000.0 (Q1 2025), and $32000.0 (Q4 2024), per Business Quant data.

Peer Comparison